We are live on ! Find out more
MC

Matisse Capital Portfolio holdings

AUM $234M
1-Year Est. Return 19.72%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+19.72%
3 Year Est. Return
+52.07%
5 Year Est. Return
+45.94%
10 Year Est. Return
+148.24%
AUM
$202M
AUM Growth
-$5.78M
Cap. Flow
-$8.32M
Cap. Flow %
-4.11%
Top 10 Hldgs %
24.45%
Holding
201
New
11
Increased
42
Reduced
22
Closed
20
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGS icon
101
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
$1.68B
$592K 0.29%
11,518
EMLC icon
102
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.76B
$592K 0.29%
24,900
VFH icon
103
Vanguard Financials ETF
VFH
$13.5B
$586K 0.29%
5,871
MA icon
104
Mastercard
MA
$500B
$586K 0.29%
1,328
VGI
105
Virtus Global Multi-Sector Income Fund
VGI
$81.7M
$583K 0.29%
77,022
+9,140
+13% +$68.1K
SOFI icon
106
SoFi Technologies
SOFI
$19.7B
$575K 0.28%
87,038
-2,622
-3% -$18.5K
EMD
107
Western Asset Emerging Markets Debt Fund
EMD
$610M
$572K 0.28%
+61,396
New +$571K
AEF
108
abrdn Emerging Markets Equity Income Fund
AEF
$335M
$557K 0.28%
105,486
LMT icon
109
Lockheed Martin
LMT
$133B
$552K 0.27%
1,181
USB icon
110
US Bancorp
USB
$98.5B
$528K 0.26%
13,290
-1,800
-12% -$73.4K
NTR icon
111
Nutrien
NTR
$33.7B
$522K 0.26%
10,256
UNP icon
112
Union Pacific
UNP
$173B
$518K 0.26%
2,291
IQI icon
113
Invesco Quality Municipal Securities
IQI
$529M
$516K 0.26%
52,037
GLQ
114
Clough Global Equity Fund
GLQ
$151M
$513K 0.25%
73,483
VRNA
115
DELISTED
Verona Pharma
VRNA
$497K 0.25%
34,400
+15,000
+77% +$219K
CVS icon
116
CVS Health
CVS
$136B
$496K 0.25%
8,391
BIIB icon
117
Biogen
BIIB
$30.6B
$486K 0.24%
+2,095
New +$455K
FISV
118
Fiserv Inc
FISV
$29.8B
$484K 0.24%
3,248
DE icon
119
Deere & Co
DE
$166B
$479K 0.24%
1,282
UNH icon
120
UnitedHealth
UNH
$384B
$474K 0.23%
930
BHV icon
121
BlackRock Virginia Muni Bond Trust
BHV
$20.3M
$455K 0.23%
41,000
TMDX icon
122
Transmedics
TMDX
$2.7B
$452K 0.22%
+3,000
New +$360K
GRF
123
Eagle Capital Growth Fund
GRF
$41.3M
$451K 0.22%
48,778
+620
+1% +$5.8K
MINV icon
124
Matthews Asia Innovators Active ETF
MINV
$154M
$444K 0.22%
16,428
-1,500
-8% -$39K
PII icon
125
Polaris
PII
$3.78B
$435K 0.22%
5,558

Similar funds

Matisse Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Matisse Capital held 201 positions worth $202M, down 2.8% from $208M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Matisse Capital withdrew a net $8.32M in Q2 2024, closing 20 positions and reducing 22 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $7.54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Matisse Capital opened a new position in PGIM Short Duration High Yield Opportunities Fund worth $1.5M.

  • Matisse Capital's largest Q2 2024 buy was PGIM Short Duration High Yield Opportunities Fund: 98,000 shares worth $1.5M.
  • Matisse Capital added most to Japan Smaller Capitalization Fund in Q2 2024, an estimated $1.26M increase.
  • Matisse Capital's biggest Q2 2024 reduction was BlackRock Science and Technology Term Trust, cutting an estimated $780K.
  • Matisse Capital fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $7.54M.
  • Matisse Capital's ten largest holdings make up 24% of its $202M portfolio in Q2 2024.
  • Matisse Capital opened 11 new positions and closed 20 in Q2 2024.
  • Matisse Capital's portfolio value fell 2.8% quarter-over-quarter to $202M.

Based on Matisse Capital's 13F filing for Q2 2024, filed 30 Jul 2024.